Back to dashboard
Low impact

Eribulin Mesylate (Halaven) (CPB 0831, reviewed 2026-06-19)

Aetna·Medical Policy
Effective date
Not stated
We identified it
Aug 13, 2026
Days to comply

Related policy hubs